Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.08 0.07
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.064 0.07
mRNA VNLG/124 GDSC1000 pan-cancer AAC -0.059 0.08
mRNA MG-132 GDSC1000 pan-cancer AAC 0.088 0.08
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.08
mRNA AZD-2281 FIMM pan-cancer AAC 0.28 0.08
mRNA QL-XII-47 GDSC1000 pan-cancer AAC -0.059 0.08
mRNA ATRA GDSC1000 pan-cancer AAC -0.061 0.08
mRNA KIN001-102 GDSC1000 pan-cancer AAC -0.053 0.08
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.064 0.08
Download CSV